All

Undercounted

by C. Scott McMillin | Mar 19, 2020 | Public Health | 0 |

Typically, the researchers report, an undercounted fatality would be a white female between the ages of 30 and 60.

Who’s Raising the Kids?

by C. Scott McMillin | Jan 13, 2020 | Thinking About Addiction | 0 |
The Return of Methamphetamine

by C. Scott McMillin | Jan 6, 2020 | Addictive Substances | 0 |
Oh– as for Fentanyl…

by C. Scott McMillin | Oct 17, 2019 | In the News, Public Health | 0 |
Politics and Drugs

by C. Scott McMillin | Oct 14, 2019 | Public Policy | 0 |
Politics and Drugs

by C. Scott McMillin | Oct 14, 2019 | Public Policy | 0 |

Fentanyl Goes West

by C. Scott McMillin | Sep 30, 2019 | Addictive Substances, Public Health | 0 |

It’s Business 101, for illegal as well as legal enterprises.

Cheaters Do Get Caught…

by C. Scott McMillin | Aug 5, 2019 | In the News | 0 |

These multi-billion dollar fines sound enormous, but like the one levied on Facebook, they represent a small portion of the company’s actual assets.

Stimulants Today

by C. Scott McMillin | Jun 17, 2019 | Addictive Substances, Public Health | 0 |

The list of deaths from the practice is long and oddly prestigious, featuring celebs such as John Belushi and Chris Farley, among many others.

Ending an Epidemic?

by C. Scott McMillin | Apr 29, 2019 | Public Health | 0 |

It’s as if we can’t conceive of life without drowning ourselves in abusable substances.

The Miracle Herb

by C. Scott McMillin | Jan 21, 2019 | Public Policy | 0 |

We focus on the drug, as if someone who uses heroin, for instance, can’t also have a problem with alcohol, or sleeping pills, or methamphetamine, or this new, more potent form of marijuana that’s showing up everywhere.

Vaping Goes Pro

by C. Scott McMillin | Jan 7, 2019 | Addictive Substances, Public Health | 0 |

It’s still just nicotine, after all, even if someone doctored it to smell like creme brulee.

Proactive is the Key

by C. Scott McMillin | Dec 6, 2018 | Prevention, Public Policy | 0 |

Not Latin American cartels or Afghan warlords, but advocates for opioid treatment of chronic pain, and pharmaceutical firms with a substantial financial interest in selling opioids.